Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 13,492 | 12,584 | 12,378 | 8,640 | 7,728 |
| Operating Income | -13,492 | -12,584 | -12,378 | -8,640 | -7,728 |
| Other Income | 247 | 163 | 224 | 79 | 59 |
| Pre-tax Income | -13,245 | -12,421 | -12,154 | -8,561 | -7,669 |
| Net Income Continuous | -13,245 | -12,421 | -12,154 | -8,561 | -7,669 |
| Minority Interests | 1 | 1 | 1 | -16 | 2 |
| Net Income | $-13,246 | $-12,422 | $-12,155 | $-8,547 | $-7,671 |
| EPS Basic Total Ops | -0.46 | -0.44 | -0.44 | -0.20 | -0.42 |
| EPS Basic Continuous Ops | -0.46 | -0.44 | -0.44 | -0.20 | -0.42 |
| EPS Diluted Total Ops | -0.46 | -0.44 | -0.44 | -0.20 | -0.42 |
| EPS Diluted Continuous Ops | -0.46 | -0.44 | -0.44 | -0.20 | -0.42 |
| EBITDA(a) | $-12,947 | $-12,101 | $-11,843 | $-8,097 | $-7,362 |